Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Site Search
Showing 1 - 8 of 8 results
Press Release
|
|
2 min read
Press Release
|
|
5 min read
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
Press Release
|
|
5 min read
Press Release
|
|
3 min read
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Press Release
|
|
3 min read
En la Fundación de la Fibrosis Quística, nos comprometemos con la igualdad, la justicia racial, la diversidad y la inclusión como principios básicos que guían nuestros esfuerzos para brindar a toda persona con fibrosis quística (FQ) la oportunidad de llevar una vida larga y plena.
Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation
Press Release
|
|
5 min read
Press Release
|
|
3 min read